Sort
30,917 grants matching “tumor microenvironment”
Prostate Cancer Bone Metastasis: Biology and Targeting
$1,508,950Emory University · P01 · FY2005 · CA
Cancer Metabolism and Growth
$1,508,494Wei-Xing Zong · Rbhs -Cancer Institute Of New Jersey · P30 · FY2021 · CA
Probing Tumor Microenvironment Using Nanotechnology
$1,507,967Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2012 · CA
The Biology of Prostate Cancer Skeletal Metastases
$1,506,835Evan Todd Keller · University Of Michigan At Ann Arbor · P01 · FY2012 · CA
Deconvolution and interruption of the cancer-neuro-immune axis facilitating brain metastases
$1,506,650Melanie Hayden Gephart · Stanford University · U54 · FY2021 · CA
p53 - Regulators and Effectors
$1,505,746Stuart A Aaronson · Icahn School Of Medicine At Mount Sinai · P01 · FY2010 · CA
Radiation Oncology-Biology Integration Network on Oligometastasis (ROBIN OligoMET) Center
$1,505,442Amit Sawant · University Of Maryland Baltimore · U54 · FY2025 · CA
Modulation of Therapeutic Response
$1,505,416James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Tumor Microenvironment Interactions in Brain Tumors
$1,503,474Eric C Holland · Sloan-Kettering Inst Can Research · U54 · FY2009 · CA
Mechanisms of esophageal carcinogenesis
$1,501,332Anil K Rustgi · University Of Pennsylvania · P01 · FY2013 · CA
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
$1,500,153Lynn M Matrisian · Vanderbilt University · U54 · FY2008 · CA
Vanderbilt In Vivo Cellular and Molecular Imaging Center
$1,500,000John C Gore · Vanderbilt University · P50 · FY2008 · CA
Vanderbilt In Vivo Cellular and Molecular Imaging Center
$1,500,000John C Gore · Vanderbilt University · P50 · FY2009 · CA
IGF::OT::IGF SBIR PHASE II TOPIC 328: SYNVIVO-TUMOR: A PHYSIOLOGICAL 3D MODEL OF THE TUMOR MICROENVIRONMENT
$1,499,854Balabhaskar Prabhakarpandian · Cfd Research Corporation · N44 · FY2016 · CA
SMALL BUSINESS INNOVATION RESEARCH PROGRAM (SBIR)
$1,499,547Hal Crosswell · Kiyatec, Inc. · N43 · FY2016 · CA
Interrupting Cellular Crosstalk in the Immunosuppressive Microenvironment of Pancreas Cancer
$1,497,616Howard C Crawford · University Of Michigan At Ann Arbor · U01 · FY2017 · CA
Therapeutic Opportunities for Pediatric Astrocytoma
$1,496,990Rosalind A Segal · Dana-Farber Cancer Inst · P01 · FY2013 · CA
Targeting the Chemokine System to Sensitize Tumors to Immunotherapy
$1,494,670Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2024 · CA
Novel Targets for Immunotherapy
$1,493,975Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
CD8+ T cells and Immunological Tumor Regression
$1,493,912Hans Schreiber · University Of Chicago · P01 · FY2009 · CA
Harnessing human brain and liver microphysiological systems for testing therapeutics for metastatic melanoma
$1,492,261John Peter Wikswo · Vanderbilt University · U01 · FY2022 · TR
Paracrine TGF-Beta Signaling in Tumor Initiation and Progression
$1,492,097Lynn M Matrisian · Vanderbilt University · U54 · FY2007 · CA
CD28-KITv CAR T cells with PD-1 dominant negative receptor
$1,491,519Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · UG3 · FY2024 · CA
Prostate inflammatory lesions as a proving ground for development of aggressive prostate cancer
$1,485,601Angelo Michael De Marzo · Johns Hopkins University · U54 · FY2023 · CA
Probing functioning lung at the cellular resolution in health and disease
$1,485,000Hadi Tavakoli Nia · Boston University (Charles River Campus) · DP2 · FY2022 · HL